Rituxan/BEAM vs Bexxar/BEAM in Autologous Hematopoietic Stem Cell Transplant for Non-Hodgkin's Lymphoma (BMTCTN0401)

NCT00329030 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

224

Enrollment

NIH

Sponsor class

Conditions

Lymphoma, B-Cell
Lymphoma, Large-Cell, Immunoblastic
Lymphoma, Non-Hodgkin

Interventions

DRUG: Autologous transplantation using rituxan/BEAM
DRUG: Autologous transplantation using Bexxar/BEAM

Sponsor

National Heart, Lung, and Blood Institute (NHLBI)

Collaborators

[object Object]
[object Object]